Alejandra Salas-Fernández

Alejandra Salas-Fernández

Auto-generated profile, based on publicly available information

Alejandra Salas-Fernández

Instituto Mexicano del Seguro Social (IMSS), National Medical Center Siglo XXI, Pediatrics Hospital, Unit of Medical Research in Nutrition, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2018 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
MPMónica Ivette Piña-Aguero
Mónica Ivette Piña-Aguero
AZAranza Zaldivar-Delgado
Aranza Zaldivar-Delgado
ASAlejandra Salas-Fernández
Alejandra Salas-Fernández
AMAzucena Martínez-Basila
Azucena Martínez-Basila
Mariela Bernabe-GarcíaMariela Bernabe-García
Mariela Bernabe-García
Jorge Maldonado-HernándezJorge Maldonado-Hernández
Jorge Maldonado-Hernández
The aim of this study was to determine optimal cut-off points for fasting and post-glucose stimulus surrogates of insulin resistance to predict metabolic syndrome in adolescents according to several definitions. One hundred fifty-five adolescents living in Mexico City were enrolled during 2011 and 2012. Waist circumference and blood pressure were recorded. Subjects received an oral glucose load of 1.75 g per kg up to a maximum dose of 75 g. Blood samples were drawn at baseline and 120 minutes. Concentrations of plasma glucose, triglycerides, high-density lipoprotein cholesterol and insulin were determined. The frequency of metabolic syndrome showed a large variability when using a variety of published definitions; in contrast, the optimal cut-off points for fasting insulin, homeostatic model assessment of insulin resistance and two-hour oral glucose tolerance test insulin were very similar in almost all the definitions considered and had adequate diagnostic performance: area under the curve >0.869, sensitivity >0.835 and specificity >0.755. Insulin resistance surrogates had substantial agreements with Ford, Cook and Salas definitions (Kappa~0.62; agreement~82%); moderate agreement was observed for International Diabetes Federation, Cruz and Ferranti definitions (Kappa~0.41–0.59; agreement~77%). Insulin resistance surrogates may be a better approach for metabolic syndrome assessment in an adolescent population because of reduced variability and a higher predictive value.